SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001395064-19-000083
Filing Date
2019-11-22
Accepted
2019-11-22 06:23:03
Documents
1
Period of Report
2019-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157442176475523.html 4  
1 FORM 4 wf-form4_157442176475523.xml 4 5266
  Complete submission text file 0001395064-19-000083.txt   7472
Mailing Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139 6176797000
MILLENNIUM PHARMACEUTICALS INC (Reporting) CIK: 0001002637 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 191238661
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 191238660
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations